If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,640.00    80.00 (1.44%)
Bid:
5,620.00
Ask:
5,640.00
Spread: 20.00 (0.356%)
Market Cap: £3.02b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director Appointments

23 Jun 2022 07:00

RNS Number : 8624P
Cranswick PLC
23 June 2022
Β 

23 June 2022

Cranswick plc(the "Company" or "the Group")

Director Appointments

Cranswick plc, aΒ leadingΒ UKΒ foodΒ producer, announces the appointment of Yetunde Hofmann as an independent Non-Executive Director of the Company and of Christopher Aldersley as an Executive Director of the Company, both with effect from 1 August 2022.

Yetunde Hofmann

Yetunde is the Managing Director of Synchrony Development Consulting, an international leadership and change consultancy that partners with leaders to facilitate strategy, change, diversity and inclusion and the founder of Solaris Global Executive Leadership Development. She is also a Trustee at the Institute of Business Ethics (IBE) and is a visiting fellow at the University of Reading's Henley Business School of Marketing and Reputation.

On appointment, Yetunde will become a member of the Audit, Remuneration, Nomination and ESG committees.

Yetunde is an independent Non-Executive Director at Treatt plc. No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Yetunde Hofmann's appointment as a Non-Executive Director of the Company.

Christopher Aldersley

Chris joined Cranswick in 1998 and since then has undertaken a variety of senior management roles, becoming the Group's Chief Operating Officer in 2015. Chris has responsibility for managing the operations at the Group's four primary processing and sixteen added value facilities and also for its agricultural operations, which support the Group's vertically integrated supply chain strategy.

The appointment of Chris to the Board recognises his contribution to the Group and central importance of his role going forward as a member of the Board to the delivery of the Group's long-term strategy.

On appointment, Chris will become a member of the ESG committee.

No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Chris Aldersley's appointment as an Executive Director of the Company.

Tim Smith, Chairman of Cranswick plc, commented:

"I am delighted that Yetunde and Chris will join our Board.

"Yetunde's experience will complement our existing Board. She has an established track record of mentoring and developing performance, talent and leadership strategies across a range of organisations, which will be invaluable to Cranswick.

"Chris's role at Cranswick has grown with the rapid development of the Group and he has been central to facing the challenges presented in recent times by Brexit and the COVID-19 pandemic. Chris helps deliver our Second Nature sustainability strategy. I am pleased his contribution is recognised with his appointment to the Board.".

Enquiries:

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Powerscourt

020 7250 1446

Nick Dibden / Nick Hayns/Chloe Retief

cranswick@powerscourt-group.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAFLFEERTIFFIF
Date   Source Headline
30th Jul 20183:34 pmRNSAGM Statement
30th Jul 20187:00 amRNSFirst quarter trading statement
26th Jul 20183:17 pmRNSDividend Declaration
23rd Jul 201812:08 pmRNSHolding(s) in Company
9th Jul 20183:53 pmRNSHolding(s) in Company
2nd Jul 201811:01 amRNSTotal Voting Rights
8th Jun 20181:07 pmRNSDirector/PDMR Shareholding
5th Jun 20184:42 pmRNSHolding(s) in Company
1st Jun 20182:39 pmRNSTotal Voting Rights
29th May 20181:53 pmRNSHolding(s) in Company
25th May 201811:32 amRNSDirector/PDMR Shareholding
25th May 201811:30 amRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSPreliminary Results
3rd May 201811:26 amRNSTotal Voting Rights
18th Apr 20184:49 pmRNSDirector/PDMR Shareholding
3rd Apr 20189:41 amRNSBlock listing Interim Review
3rd Apr 20189:36 amRNSBlock listing Interim Review
3rd Apr 20189:34 amRNSTotal Voting Rights
13th Mar 20182:22 pmRNSDirector/PDMR Shareholding
13th Mar 20181:59 pmRNSDirector/PDMR Shareholding
5th Mar 20187:00 amRNSDirectorate Change
2nd Mar 201810:00 amRNSTotal Voting Rights
14th Feb 201811:03 amRNSDirector/PDMR Shareholding
13th Feb 201812:13 pmRNSDirector/PDMR Shareholding
13th Feb 201812:08 pmRNSDirector/PDMR Shareholding
1st Feb 20189:58 amRNSTotal Voting Rights
1st Feb 20187:00 amRNSThird Quarter Trading Statement
29th Jan 20183:57 pmRNSHolding(s) in Company
29th Jan 20182:14 pmRNSDirector/PDMR Shareholding
29th Jan 20182:13 pmRNSDirector/PDMR Shareholding
29th Jan 20182:13 pmRNSDirector/PDMR Shareholding
26th Jan 20189:36 amRNSDirector/PDMR Shareholding
26th Jan 20189:36 amRNSDirector/PDMR Shareholding
24th Jan 20189:54 amRNSAdditional Listing
19th Jan 201811:40 amRNSDirector/PDMR Shareholding
17th Jan 201810:45 amRNSDirector/PDMR Shareholding
17th Jan 201810:45 amRNSDirector/PDMR Shareholding
9th Jan 20189:02 amRNSDirector/PDMR Shareholding
2nd Jan 201812:23 pmRNSTotal Voting Rights
14th Dec 20172:52 pmRNSDividend Declaration
4th Dec 201711:47 amRNSTotal Voting Rights
28th Nov 20177:00 amRNSHalf-year Report
2nd Nov 20172:00 pmRNSTotal Voting Rights
25th Oct 201710:01 amRNSBlock listing Interim Review
25th Oct 201710:01 amRNSBlock listing Interim Review
2nd Oct 20179:24 amRNSTotal Voting Rights
21st Sep 20174:31 pmRNSDirector/PDMR Shareholding
14th Sep 20171:52 pmRNSDirector/PDMR Shareholding
14th Sep 20179:15 amRNSHolding(s) in Company
5th Sep 201711:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.